Monday, October 26, 2026
ExploreSearch
Via News
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· December 13, 2025

Bitcoin 2030 Price Prediction: Will BTC Hit $500K or $1M?

View original at finance.yahoo.com
Bitcoin 2030 Price Prediction: Will BTC Hit $500K or $1M? Travis Wolfe / Shutterstock.com Quick Read Bitcoin trades around $90K after hitting $126K in October, marking a 26.3% correction from the peak…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Price acceleration typically peaks 12-24 months after a halving event

    80% confidence

  • Base case projects Bitcoin at $350K-$500K with ETF assets moving toward $500-$800 billion range

    80% confidence

  • Bullish case projects Bitcoin at $750K-$1M by 2030 if ETF assets approach $2 trillion and sovereign reserves expand

    80% confidence

  • Institutions now treat Bitcoin as a modern counterpart to gold for navigating unstable monetary conditions

    80% confidence

  • Bitcoin could reach $500K to $1M by 2030 depending on institutional demand, supply compression, and adoption patterns

    80% confidence

  • Banks now use Bitcoin as collateral in lending markets

    80% confidence

  • Global ETF demand could exceed $500-$800 billion by 2030

    80% confidence

  • Bearish case projects Bitcoin at $120K-$220K if structural demand weakens and ETF inflows flatten

    80% confidence

  • At $500K, Bitcoin's market cap would reach approximately $10 trillion, roughly 2% of global wealth and still below gold

    80% confidence

  • Hundreds of publicly traded companies now hold Bitcoin following MicroStrategy's accumulation model

    80% confidence

Data points we hold from this source

Bitcoin · daily issuance225 BTC
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biotech Catalyst Window: ESMO Data, the Ivonescimab PDUFA and Small-Cap Delistings
Mid-October to November 2026 is a dense catalyst period for clinical-stage biotech. Positive late-stage readouts (ALOFT-IPF, TELIGAN, MIUDELLA, the duvakitug extension) and the ESMO 2026 presentations lead up to the FDA's 14 November PDUFA date for the ivonescimab BLA. At the opposite end of the market, Spago Nanomedical is moving to delist from Nasdaq First North, which shows how hard it is for micro-cap developers to fund themselves. Value is concentrating in companies with late-stage data and near-term regulatory outcomes.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,994
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,994 facts checked against source5,500 source documents archived
Query this data → isubstrate.com
Bitcoin 2030 Price Prediction: Will BTC Hit $500K or $1M? — Source | Via News | ViaNews Market